The Marseille Public Hospitals and the Mediterranean Infection Foundation have reported to the National Agency for the Safety of Medicines and Health Products a new publication deemed problematic by the controversial professor Didier Raoult.
Professor Didier Raoult once again wanted to demonstrate the effectiveness of the controversial treatment of hydroxychloroquine on patients with Covid-19. His article, published in the August 2024 edition of the journal “Acta Scientific Microbiology” was the subject of a report from the Assistance publique-Hôpitaux de Marseille and the Fondation Méditerranée Infection to the National Agency for the Safety of Medicines and Health Products (ANSM), we learned this Thursday, September 5 from the APHM, confirming information from Le Point.
The article co-signed by Didier Raoult, former head of the IHU Méditerranée Infection in Marseille, and one of his former close collaborators, Philippe Brouqui, focused on data from 1,276 Covid patients treated at the IHU, some of whom were treated with hydroxychloroquine.
“Unauthorized patient and research data”
In their letter, the APHM and the Mediterranean Infection Foundation, which oversees the IHU, “report” and “dissociate themselves” from this article whose methodology is based on “the use of patient data and unauthorized research”, specified the APHM. According to the establishment, this report was decided in a “logic of return to normal” at the IHU since the departure of Professor Raoult, now retired.
The ANSM had taken legal action in November 2023 after the publication of another study co-signed by Professor Raoult, who had not obtained the mandatory authorizations. The former head of the IHU and his team are suspected of having conducted several “wild” studies at the IHU during the Covid epidemic.
Related News :